UBS Group’s CareMax, Inc. Warrant CMAXW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,941
| Closed | -$79 | – | 10797 |
|
|
2024
Q3 | $79 | Buy |
7,941
+7,891
| +15,782% | +$122 | ﹤0.01% | 9183 |
|
|
2024
Q2 | $1 | Hold |
50
| – | – | ﹤0.01% | 9453 |
|
|
2024
Q1 | $1 | Sell |
50
-50
| -50% | -$1 | ﹤0.01% | 9225 |
|
|
2023
Q4 | $1 | Sell |
100
-1,861
| -95% | -$205 | ﹤0.01% | 9220 |
|
|
2023
Q3 | $392 | Buy |
1,961
+1,960
| +196,000% | +$510 | ﹤0.01% | 8523 |
|
|
2023
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 10435 |
|
|
2022
Q4 | – | Sell |
-3,344
| Closed | -$5K | – | 12016 |
|
|
2022
Q3 | $5K | Hold |
3,344
| – | – | ﹤0.01% | 9305 |
|
|
2022
Q2 | $2K | Hold |
3,344
| – | – | ﹤0.01% | 9771 |
|
|
2022
Q1 | $5K | Buy |
3,344
+1,627
| +95% | +$2.17K | ﹤0.01% | 9258 |
|
|
2021
Q4 | $2K | Sell |
1,717
-3
| -0.2% | -$5 | ﹤0.01% | 9936 |
|
|
2021
Q3 | $5K | Buy |
1,720
+88
| +5% | +$256 | ﹤0.01% | 8613 |
|
|
2021
Q2 | $8K | Buy |
1,632
+621
| +61% | +$2.54K | ﹤0.01% | 8297 |
|
|
2021
Q1 | $2K | Buy |
+1,011
| New | +$3.57K | ﹤0.01% | 8733 |
|
UBS Group's CMAXW Position: Q4 2024 in Review
UBS Group sold out of CareMax, Inc. Warrant (CMAXW) in Q4 2024, closing a stake of 7,941 shares — an estimated $79 sold.
UBS Group first reported a position in CMAXW in Q1 2021 and held it in 13 quarters. The position peaked at $8K in Q2 2021. 0 funds tracked by Wall St. Rank hold CMAXW as of Q4 2024.
- UBS Group reported no remaining CareMax, Inc. Warrant position as of Q4 2024 after selling out during the quarter.
- UBS Group sold 7,941 CareMax, Inc. Warrant shares in Q4 2024, an estimated $79.
- UBS Group first reported a position in CareMax, Inc. Warrant in Q1 2021 and held it in 13 quarters.
- UBS Group's CareMax, Inc. Warrant position peaked at $8K in Q2 2021.
- 0 funds tracked by Wall St. Rank held CareMax, Inc. Warrant as of Q4 2024.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.